期刊文献+

干粉试剂与液体试剂测定PT与INR结果的分析 被引量:1

Analyze Results of Prothrombin Time and International Standardizatoin Ratio that were Measured by Dry Reagent and Liquid Reagent
下载PDF
导出
摘要 目的:分析干粉试剂与液体试剂对相同的标本测得凝血酶原时间(PT)和国际标准化比值(INR)结果的差异性。方法:用干粉试剂和液体试剂在同一台全自动血凝仪测定病人标本与健康人标本凝血酶原时间与INR的结果,应用统计学方法对测定结果进行分析。结果:干粉试剂与液体试剂测出的每组凝血酶原时间和INR的结果均有显著性差异。结论:依据对照组得出,液体试剂测出的结果能更准确地反映病人的实际状况,更适合实验室应用。 Objective:Analyze results differences of the PT and INR that were measured by dry reagent and liquid reagent to same sample. Methods:The PT and INR were measured by dry reagent and liquid reagent in same Automated Blood Coagulation Analyzer in patients and healthy people,Analyze results with statistical methods. Resuits:There were significant differences in each set of results that were measured by dry reagent and liquid reagent. Conclusion:According to the comparisinn,The results of PT and INR that were measured by liquid reagent can reflect actual level of patients more exactly,The liquid reagent is more suitable for lab than dry reagent.
作者 邱伟
出处 《医学信息(中旬刊)》 2011年第7期3148-3149,共2页 Medical Information Operations Sciences Fascicule
关键词 全自动血凝仪 凝血酶原时间 INR Automated Blood Coagulation Analyzer Prothrembin Time INR
  • 相关文献

参考文献5

二级参考文献17

  • 1董力,石应康,赵雍凡,沈发扬,肖锡俊.心脏机械瓣替换术后126例抗凝治疗随访[J].中华胸心血管外科杂志,1996,12(3):149-151. 被引量:43
  • 2BRAUNWALD E.心脏病学[M].陈灏珠,译.北京:人民卫生出版社,2000:1662—1665.
  • 3Milosevic U, Anojcic S. Anticoagulation therapy in cardiac patients with mechanical valve prostheses. Srp Ath Celok Lek ,1990,118:481-483.
  • 4Canegieter SL, Torn M, Recendial FR. Oral anticoagulation treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications. J Intern Med, 1999,245: 369-374.
  • 5Neau JP, Couderq C, Lngrand P, et al. Intracranial hemarrhage and oral anticoagulant treatment. Cerebravasc Dis, 2001,11:195-200.
  • 6Robert GH, Bradleg SB, David CA. Oral anticoagulants and intracranial hemorrhage. Stroke, 1995,26:1471-1477.
  • 7Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fatal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol, 1999, 33:1637-1641.
  • 8Schenk JF, Morsdorf S, Pindur G, et al. Analysis and occurrence of adverse events with oral anticoagulant therapy. Semin Tthromb Hemost, 1999, 25: 64-71.
  • 9Katircioglu SF, Yamak B, Ulus AT, et al. Aortic valve replacement with the St. Jude medical prosthesis and fixed dose anticoagulation. J Card Surg, 1997,12:363-370.
  • 10Karthik A, John NB, Aocoard SR, et al. How safety and how long can wanfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage. Chest, 2001,119:478-484.

共引文献67

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部